A growing body of evidence suggests that insulin metabolism-related disorders such as central obesity, IR, and hyperinsulinemia can contribute to the progression and development of kidney dysfunction and an increased risk of CKD [31]. This evidence concerns the gene INS and hyperinsulinism.